A New Study Links GLP-1 Medications to Lower Epilepsy Risk
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellnessGLP-1s A New Study Links GLP-1 Medications to Lower Epilepsy Risk The findings come from one of the largest datasets examined to date. Marisa Petrarca Published: Dec 16, 2025 Matthias Clamer / Getty Images Ozempic and other GLP-1 medications have become household names for managing type 2 diabetes—and, more recently, weight loss. Now, new research suggests they may be doing something else worth paying attention to: supporting brain health. A large analysis published December 10 in Neurology, the medical journal of the American Academy of Neurology, found that people with type 2 diabetes who took GLP-1 medications were modestly less likely to develop epilepsy than those taking another common class of diabetes drugs. One word matters here: association. The findings don’t prove that GLP-1 drugs prevent epilepsy, but they do add to growing curiosity around their potential neurological effects.